Biotech Stocks At 52-Week Highs - RNXT +15%, EOLS, CRNX, APGErttnews·Sep 1 at 07:46 AMEOLS+2.76%RNXT+0.84%
Evolus posts scientific investor presentation on Jeuveau, Evolysse HA fillers, Profhilo skin-quality injectable portfolioPUBT·Aug 5 at 10:12 PMEOLS+2.76%
EOLS: Q2 revenue up 21%, positive EBITDA, raised outlook, and expanded global portfolio for sustained growthQuartr·Aug 5 at 10:04 PMEOLS+2.76%
Evolus Q2 2026 Earnings: Revenue Rises 21% as Adjusted EBITDA Stays PositiveTradingKey·Aug 5 at 08:48 PMEOLS+2.76%
Evolus Q2 GAAP operating loss narrows to USD 4.5 million; revenue increases 21% to USD 84.1 million vs year-ago quarterPUBT·Aug 5 at 08:25 PMEOLS+2.76%
Evolus expands Symatese partnership to commercialize Estyme HA gels in Canada, Australia, New ZealandPUBT·Aug 4 at 12:31 PMEOLS+2.76%
Evolus to report second-quarter results after markets close, host conference callPUBT·Jul 22 at 12:30 PMEOLS+2.76%
